Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component
- 24 June 2008
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (25) , 8709-8712
Abstract
Bacillus anthracis is a spore-forming bacterium that causes anthrax in humans and in other mammals. The glycoprotein BclA (Bacillus collagen-like protein of anthracis) is a major constituent of the exosporium, the outermost surface of B. anthracis spores. The glycosyl part of BclA is an oligosaccharide composed of 2-O-methyl-4-(3-hydroxy-3-methylbutanamido)-4,6-dideoxy-d-glucose, referred to as anthrose, and three rhamnose residues. A structure similar to anthrose, 4-(3-hydroxy-3-methylbutanamido)-4,6-dideoxy-d-glucose is found in the side chain of the capsular polysaccharide (CPS) of Shewanella spp. MR-4. Under certain growth conditions the bacteria produce a variant CPS lacking one methyl group on the hydroxybutyrate, 4-(3-hydroxybutanamido)-4,6-dideoxy-d-glucose. Contrary to anthrose, neither of the Shewanella CPSs is 2-O methylated. Here, we report that both Shewanella CPS variants react with anti-B. anthracis spore sera. We also found that these antisera reacted with flagellae of Pseudomonas syringae, reported to be glycosylated with a similar terminal saccharide, 4-(3-hydroxybutanamido)-4,6-dideoxy-2-O-methyl-d-glucose. Sera produced by immunization with Shewanella or P. syringae cells bound to B. anthracis spores but not to Bacillus cereus spores in a fluorescent microscopy assay. These experiments show that methylation of the anthrose at the O-2 of the sugar ring and at the C-3 of 3-hydroxybutyrate are not essential for induction of cross-reactive antibodies. We report the preparation, characterization, and antibody responses to protein conjugates of the two variants of Shewanella CPS. Both conjugates induced antibodies that bound to both Shewanella CPS variants by ELISA and to B. anthracis spores, as detected by fluorescent microscopy. We propose the use of Shewanella CPS conjugates as a component of an anthrax vaccine.Keywords
This publication has 25 references indexed in Scilit:
- Anthrose Biosynthetic Operon of Bacillus anthracisJournal of Bacteriology, 2008
- Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelVaccine, 2008
- Flagellin Glycans from Two Pathovars of Pseudomonas syringae Contain Rhamnose in d and l Configurations in Different Ratios and Modified 4-Amino-4,6-DideoxyglucoseJournal of Bacteriology, 2007
- Synthesis of the Antigenic Tetrasaccharide Side Chain from the Major Glycoprotein of Bacillus anthracis ExosporiumThe Journal of Organic Chemistry, 2007
- Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmidsMicrobiology, 2006
- Identification of glycosylation genes and glycosylated amino acids of flagellin in Pseudomonas syringae pv. tabaciCellular Microbiology, 2006
- Genome Engineering in Bacillus anthracis Using Cre RecombinaseInfection and Immunity, 2006
- Bacillus anthracisJournal of Clinical Pathology, 2003
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.Journal of Experimental Medicine, 1980
- BACTERIAL ANTIGENS CROSS-REACTIVE WITH THE CAPSULAR POLYSACCHARIDE OF HÆMOPHILUS INFLUENZÆ TYPE bThe Lancet, 1971